| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |